Experiences of serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT)

Experiences of serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT)

Background: This study aims to provide evidence of factors that impact participant reported serious depression and serious anxiety among individuals receiving injectable opioid agonist treatment (iOAT). Methods: Data from an 18-month longitudinal retrospective cohort of individuals receiving iOAT wa...

Повний опис

Бібліографічні деталі
Автори:	Tianna Magel, Ying C MacNab, Scott MacDonald, Eugenia Oviedo-Joekes
Формат:	Стаття
Мова:	English
Опубліковано:	Elsevier 2024-01-01
Серія:	Journal of Affective Disorders Reports
Предмети:	Depression Anxiety Injectable opioid agonist treatment Opioid use disorder Person-centered care
Онлайн доступ:	http://www.sciencedirect.com/science/article/pii/S2666915323002329

Схожі ресурси

Shared decision-making and client-reported dose satisfaction in a longitudinal cohort receiving injectable opioid agonist treatment (iOAT)
за авторством: Scott Beaumont, та інші
Опубліковано: (2024-01-01)

Practitioner perspectives on working with older patients in opioid agonist treatment (OAT) in Norway: opportunities and challenges
за авторством: John Todd-Kvam, та інші
Опубліковано: (2024-05-01)

Challenges for the implementation of injectable opioid agonist treatment: a scoping review
за авторством: Tanja Schwarz, та інші
Опубліковано: (2024-12-01)

Care cascade for patients with opioid use disorder and serious injection related infections
за авторством: Anand Upadhyaya, та інші
Опубліковано: (2021-11-01)

Opioid consumption frequency and its associations with potential life problems during opioid agonist treatment in individuals with prescription-type opioid use disorder: exploratory results from the OPTIMA Study
за авторством: Anne Bouthillier, та інші
Опубліковано: (2025-02-01)

Neurocognitive performance of patients undergoing intravenous versus oral opioid agonist treatment: a prospective multicenter study on three-month treatment effects
за авторством: Sunsha Chamakalayil, та інші
Опубліковано: (2024-07-01)

Corrigendum: Precautions in the management of opioid agonist therapy: from target population characteristics to new formulations and post-marketing monitoring – a focus on the Italian system
за авторством: Guido Mannaioni, та інші
Опубліковано: (2023-12-01)

Clinical Outcomes of Benzodiazepine Prescribing for People Receiving Opioid Agonist Treatment: A Systematic Review of the Evidence
за авторством: Catriona Matheson, та інші
Опубліковано: (2024-10-01)

Pain Intensity in Patients with Opioid Use Disorder on Extended-Release Naltrexone or Opioid Agonists; The Role of COMT rs4680 and OPRM1 rs1799971: An Exploratory Study
за авторством: Juya F, та інші
Опубліковано: (2025-02-01)

Barriers and facilitators to opioid agonist treatment (OAT) engagement among individuals released from federal incarceration into the community in Ontario, Canada
за авторством: Cayley Russell, та інші
Опубліковано: (2022-12-01)

An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort study
за авторством: Rukaiyah Lakkadghatwala, та інші
Опубліковано: (2024-02-01)

Measuring sustainability of opioid agonist therapy programs in the context of transition from Global Fund support
за авторством: Raminta Stuikyte, та інші
Опубліковано: (2024-01-01)

Receipt of medications for opioid use disorder among rural and urban veterans health administration patients
за авторством: Olivia C. Reynolds, та інші
Опубліковано: (2025-03-01)

Opioid system and related ligands: from the past to future perspectives
за авторством: Laura Rullo, та інші
Опубліковано: (2024-10-01)

Exploring dual diagnosis in opioid agonist treatment patients: a registry-linkage study in Czechia and Norway
за авторством: Gabriela Rolová, та інші
Опубліковано: (2024-05-01)

Are the self-stigma and perceived stigma of patients treated with methadone or buprenorphine still a problem fifty years after the marketing authorization for opioid agonist treatment? The observational STIGMA study
за авторством: Mélanie Pinhal, та інші
Опубліковано: (2024-10-01)

The association between benzodiazepine co-prescription, opioid agonist treatment and mortality: a systematic review
за авторством: Christine Hillestad Hestevik, та інші
Опубліковано: (2024-10-01)

Sustainability of opioid agonist therapy programmes in Belarus, the Republic of Moldova, Tajikistan and Ukraine in the context of transition from Global Fund support during 2020–2023
за авторством: Raminta Stuikyte, та інші
Опубліковано: (2024-10-01)

Initiation and rapid titration of methadone and slow-release oral morphine (SROM) in an acute care, inpatient setting: a case series
за авторством: Laura Rodger, та інші
Опубліковано: (2023-12-01)

Benzodiazepine agonist treatment for patients with benzodiazepine dependence undergoing opioid agonist treatment: a study protocol for the randomized controlled trial BMX-BAR
за авторством: Fatemeh Chalabianloo, та інші
Опубліковано: (2025-01-01)

Frontline Perspectives on Buprenorphine for the Management of Chronic Pain
за авторством: Adler J, та інші
Опубліковано: (2024-03-01)

Patterns of care contacts in the final year of life among opioid overdose fatalities in southern Sweden: a latent class analysis
за авторством: Björn Johnson, та інші
Опубліковано: (2024-10-01)

Reframing the response to the opioid crisis: The critical role of resilience in public health
за авторством: Roberts Donna L.
Опубліковано: (2024-01-01)

Are we missing the opioid consumption in low- and middle-income countries?
за авторством: Correia Igor, та інші
Опубліковано: (2023-11-01)

Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)
за авторством: Sean T. Allen, та інші
Опубліковано: (2023-12-01)

OPIOIDS IN PAIN SYNDROME MANAGEMENT (part 2)
за авторством: D. M. Arbuck, та інші
Опубліковано: (2018-01-01)

OPIOIDS IN PAIN SYNDROME MANAGEMENT (part 1)
за авторством: D. M. Arbuck, та інші
Опубліковано: (2018-01-01)

High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
за авторством: Samy J. Galvez, та інші
Опубліковано: (2023-11-01)

Corrigendum: High perceived stress in patients on opioid agonist therapies during rapid transitional response to the COVID-19 pandemic in Ukraine
за авторством: Samy J. Galvez, та інші
Опубліковано: (2024-01-01)

Models of neuroinflammation for the assessment of kappa-opioid receptor ligands
за авторством: K. Yu. Kalitin, та інші
Опубліковано: (2023-05-01)

Opioids and Cancer: Current Understanding and Clinical Considerations
за авторством: Dhananjay Sah, та інші
Опубліковано: (2024-05-01)

Can the type of subjective response to first opioid exposure predict the risk of opioid use disorder? A scoping review
за авторством: Christian J. Morris, та інші
Опубліковано: (2022-10-01)

Serious treatment-emergent adverse events in chronic low back pain patients treated with buprenorphine or oral opioids: a retrospective commercial claims analysis
за авторством: Filip Stanicic, та інші
Опубліковано: (2024-07-01)

Management of hepatitis C in opioid agonist therapy patients of the Swiss canton Aargau within and outside the cohort study
за авторством: Sophie Schürch, та інші
Опубліковано: (2020-08-01)

Opioid use and disposal patterns of emergency department patients
за авторством: Valerie Hoerster, та інші
Опубліковано: (2023-01-01)

Low opioid and opioid-free anesthesia - a review of current data
за авторством: Dorota Czeremańska-Koczkodaj, та інші
Опубліковано: (2024-01-01)

Acil Serviste Akut Ağrı Tedavisinde Opioid Kullanımı
за авторством: Onur Yeşil, та інші
Опубліковано: (2011-06-01)

Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
за авторством: Madigan L. Bedard, та інші
Опубліковано: (2024-06-01)

Hepatitis C virus elimination in Swiss opioid agonist therapy programmes – the SAMMSU cohort
за авторством: Andrea Bregenzer, та інші
Опубліковано: (2021-03-01)

Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland
за авторством: Eshan U. Patel, та інші
Опубліковано: (2024-05-01)